S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Function Links Personal Lab Data to Mainstream AI Platforms

Austin-based health firm Function has launched a secure data connector that integrates individual lab results and clinical notes into mainstream AI tools like ChatGPT, Claude, and Perplexity. The move aims to shift health-related AI queries away from generalized population averages toward insights grounded in a user's specific biology.

Function Links Personal Lab Data to Mainstream AI Platforms
Photo: Bio & News

For many, navigating a cardiology appointment or interpreting concerning lab results involves a search for clarity that generic AI models often fail to provide. With over 80 percent of Function members presenting at least one biomarker outside the optimal range, the demand for personalized context has become critical. The new integration allows members to feed 160-plus lab markers and longitudinal health history into their preferred AI interfaces, enabling responses tailored to their unique biomarker patterns.

Ziad Sultan, Chief Product and Technology Officer at Function, noted that while AI has become a common tool for daily tasks, it has historically lacked the biological context required for meaningful health guidance. By bridging this gap, the company seeks to move past the limitations of static health data. This rollout expands on the company's existing Private AI Chat, providing users the flexibility to analyze their own health trends across heart function, metabolism, and hormone levels without being confined to a single proprietary ecosystem.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!